Startseite
SX

Über das Mitglied

Biografie

I have strong interest in Pharmacoepidemiology and Pharmacovigilance. With the guidance of my supervisors and collaborators, I did seven projects to identify novel adverse events associated with drugs using the FAERS database during my master's program. I am doing my PhD research which focuses on cardiovascular toxicity associated with immune checkpoint inhibitors.

Ausbildung

  • Sorbonne Université
    Abschluss PhD student
    Startdatum 01/2024
  • Central South University
    Abschluss Master
    Studienrichtung The Second Xiangya Hospital
    Startdatum 01/2021
    Enddatum 01/2024
  • China Pharmaceutical University
    Abschluss bachelor degree
    Studienrichtung College of Pharmacy
    Startdatum 01/2015
    Enddatum 01/2019

Berufserfahrung

KP

Quality Assurance Specialist

Kidos Pharmaceutical Corporation •

01/2019 – 01/2020 •

Department of Quality Assurance